|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.00 PLN | +0.68% |
|
-1.00% | -12.63% |
| May. 27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| May. 15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
| Market Cap | 377M 98.93M 87.01M 80.83M 74.34M 139M 9.58B 142M 967M 4.67B 371M 363M 16.21B | P/E 2026 * |
-6.92x | P/E 2027 * | 0.94x |
|---|---|---|---|---|---|
| Enterprise Value | 280M 73.45M 64.6M 60.02M 55.2M 104M 7.11B 105M 718M 3.47B 276M 270M 12.04B | EV / Sales 2026 * |
112x | EV / Sales 2027 * | - |
| Free-Float |
77.15% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.68% | ||
| 1 week | -1.00% | ||
| Current month | +0.34% | ||
| 1 month | -1.16% | ||
| 3 months | -15.48% | ||
| 6 months | -17.36% | ||
| Current year | -12.63% |
| 1 week | 117 |  | 120 |
| 1 month | 117 | | 128.6 |
| Current year | 109 | | 159.2 |
| 1 year | 109 | | 182.2 |
| 3 years | 109 | | 239 |
| 5 years | 83 | | 348 |
| 10 years | 9.55 | | 348 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcin Izydorzak
PRN | Corporate Officer/Principal | 52 | - |
Piotr Garstecki
CEO | Chief Executive Officer | 50 | - |
Szymon Ruta
DFI | Director of Finance/CFO | 50 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 51 | 2017-03-06 | |
| Director/Board Member | 50 | 2017-03-06 | |
| Director/Board Member | 63 | 2017-03-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/15/26 | Buy | Chairman | 36,000 | 1.1363% | ||
| 1/15/26 | Others | Chairman | 140,000 | 4.4188% | ||
| 1/15/26 | Others | Chairman | 140,000 | 4.4188% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.68% | -1.00% | -24.30% | -29.17% | 98.74M | |
| -0.22% | -2.26% | +139.07% | +102.52% | 4.63B | |
| +1.64% | +0.95% | +105.24% | +176.11% | 3.51B | |
| -0.77% | +10.09% | +29.22% | -33.12% | 2.31B | |
| -1.76% | -3.16% | -28.19% | -36.48% | 2.13B | |
| -0.45% | -6.77% | +186.66% | +253.81% | 1.95B | |
| -0.70% | -0.56% | +169.08% | -43.60% | 1.05B | |
| +2.42% | -3.50% | -8.01% | +28.14% | 830M | |
| +0.67% | -7.13% | -38.55% | -13.58% | 494M | |
| +6.72% | -9.36% | -4.60% | - | 407M | |
| Average | +0.82% | -1.31% | +52.56% | +44.96% | 1.74B | |
| Weighted average by Cap. | +0.16% | +0.04% | +88.05% | +82.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.5M 656K 577K 536K 493K 924K 63.53M 941K 6.41M 30.99M 2.46M 2.41M 108M | - |
| Net income | -54.4M -14.27M -12.55M -11.66M -10.73M -20.12M -1.38B -20.48M -139M -674M -53.59M -52.43M -2.34B | 400M 105M 92.43M 85.87M 78.97M 148M 10.18B 151M 1.03B 4.96B 395M 386M 17.22B |
| Net Debt | -97.1M -25.48M -22.41M -20.82M -19.15M -35.91M -2.47B -36.55M -249M -1.2B -95.66M -93.59M -4.18B | -494M -130M -114M -106M -97.45M -183M -12.56B -186M -1.27B -6.13B -487M -476M -21.25B |
Employees
157
Calendar
Sep. 29
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | PLN 119.00 | +0.68% | 1,080 |
| 26-07-22 | PLN 118.20 | -0.51% | 702 |
| 26-07-21 | PLN 118.80 | -0.67% | 990 |
| 26-07-20 | PLN 119.60 | -0.33% | 1,450 |
| 26-07-17 | PLN 120.00 | -0.17% | 312 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
119.00PLN
Average target price
198.20PLN
Spread / Average Target
+66.55%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCP Stock
Select your edition
All financial news and data tailored to specific country editions
